SC Pharmaceuticals Inc (SCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 118,298 | N/A | N/A | N/A | 39,282 |
| Receivables | 655 | N/A | N/A | N/A | 349 |
| Other current assets | 107 | 0 | 0 | 0 | 109 |
| TOTAL | $119,883 | $N/A | $N/A | $N/A | $39,740 |
| Non-Current Assets | |||||
| PPE Net | 203 | N/A | N/A | N/A | 35 |
| Other Non-Current Assets | 1,962 | 0 | 0 | 0 | 6 |
| TOTAL | $2,165 | $N/A | $N/A | $N/A | $41 |
| Total Assets | $122,048 | $N/A | $N/A | $N/A | $39,772 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 314 | N/A | N/A | N/A | 0 |
| Accounts payable and accrued liabilities | 1,591 | 0 | 0 | 0 | 1,540 |
| Accrued Expenses | 3,063 | N/A | N/A | N/A | 2,170 |
| Other current liabilities | 1 | N/A | N/A | N/A | 10 |
| TOTAL | $5,211 | $N/A | $N/A | $N/A | $3,736 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,105 | N/A | N/A | N/A | 0 |
| Other Non-Current Liabilities | 1,735 | 0 | 0 | 0 | 7 |
| TOTAL | $10,840 | $N/A | $N/A | $N/A | $7 |
| Total Liabilities | $16,051 | $N/A | $N/A | $N/A | $3,743 |
| Shareholders' Equity | |||||
| Common Shares | 2 | N/A | N/A | N/A | 0 |
| Retained earnings | -67,016 | N/A | N/A | N/A | -43,199 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 73,108 |
| TOTAL | $105,997 | $N/A | $N/A | $N/A | $36,029 |
| Total Liabilities And Equity | $122,048 | $0 | $0 | $0 | $39,772 |